Mission

PRIMARY MISSION

To prevent, treat, and cure antiphospholipid antibody (aPL) associated clinical manifestations through high-quality, multicenter, and multidisciplinary clinical research. 

SECONDARY MISSION

To refine and advance the definitions of aPL associated clinical manifestations through international collaboration and data sharing. 

APPROACH

Members are working together to create a research alliance that will design and conduct clinical trials, and collect data via an international registry.